Archives

In the Technical Report Risk for SARS-CoV-2 transmission from newly infected individuals with documented previous infection or vaccination, published today, ECDC examines the evidence on the extent previous SARS-CoV-2 infection or COVID-19 vaccination prevents onward transmission from infected individuals to susceptible contacts.

The aim of this document is to provide a summary of the available scientific evidence on the risk of SARS-CoV-2 transmission to susceptible contacts from infected individuals with documented previous infection or vaccination.

This technical report provides an updated overview of the progress of national COVID-19 vaccination strategies including vaccine deployment plans and their rollout in the EU/EEA. It also provides new insights into some of the critical aspects and challenges of the implementation.

The aim of this report is to share the challenges countries are facing with the rollout of the COVID-19 vaccine deployment process. It also aims to share lessons learned and good practice that countries have put in place to mitigate the challenges.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 March 2021 and includes updates on COVID-19, seasonal influenza and Ebola virus disease, chikungunya, dengue and influenza A(H5N6).

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 March 2021 and includes updates on COVID-19, seasonal influenza and Ebola virus disease.

ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, organised a stress test of the logistical aspects of COVID-19 vaccination deployment plans for EU/European Economic Area (EEA) countries.

The downloadable data file is updated daily and contains the latest available public data on COVID-19. Each row/entry contains the number of new cases and deaths reported per day and per country in the EU/EEA.

This document outlines the public health considerations for the use of self-tests to detect SARS-CoV-2 by public health authorities in the European Union/European Economic Area (EU/EEA). Only rapid antigen detection tests (RADTs) for self-testing for direct detection of SARS-CoV-2 virus particles in infectious individuals are considered within this document.

This document presents a coherent, yet non-prescriptive framework for tuning COVID-19 response measures in the European Union and European Economic Area (EU/EEA). Its aim is to ensure efficiency and encourage public trust and compliance, while continuing to protect the health of European citizens.